FDA Revising ‘Draft Guidance’ on Developing Treatments for Rare Diseases
News
The U.S. Food and Drug Administration(FDA) is updating its 2015 draft guidelines for drug discovery in rare diseases, with new guidance on natural history— how disorders such as spinal ... Read more